Latest Articles
Having endometriosis can increase ovarian cancer risk 4.2-fold - TechTarget
Having endometriosis can increase ovarian cancer risk 4.2-fold TechTarget
Published: July 19, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today
Published: July 5, 2024, 7 a.m.
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More - Targeted Oncology
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More Targeted Oncology
Published: June 23, 2024, 7 a.m.
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology - Nature.com
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology Nature.com
Published: June 18, 2024, 7 a.m.
FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget
FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget
Published: May 31, 2024, 7 a.m.
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca - Wiley Online Library
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca Wiley Online Library
Published: Feb. 11, 2024, 8 a.m.
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology
Published: Jan. 5, 2024, 8 a.m.
Link copied to clipboard!